Demand
for antibiotics remains high due to
escalating bacterial resistance and
the increased risk of serious infections.
Infectious diseases
cause more than 13 million deaths
each year. We have many years of experience
in this area of medicine, including
‘Meronem’, our antibiotic for serious
hospital-acquired infections.
AstraZeneca’s experience
in infectious diseases includes the
key product ‘Meronem’ which was launched
recently in India. AZ Research &
Development is focused on novel approaches
to the treatment of microbial diseases.
Key
Products
More information
about our products is available by
clicking on the product names below.
.gif) Meronem
(Meropenem)
Vancocin
® Injection (Vancomycin Hydrochloride)
|